Management of Parasympathetic Discharge After Coronary Artery Stenting

Understanding Parasympathetic Discharge Post-Stenting

Vasovagal responses with symptomatic bradycardia can occur during or after femoral sheath removal, according to the American Heart Association 1

Continuous electrocardiographic monitoring is recommended immediately after intervention until femoral sheaths are removed to detect vasovagal responses with symptomatic bradycardia, as suggested by the American Heart Association 1
After uncomplicated PCI without complications, continuous monitoring beyond femoral sheath removal is not recommended (Class III: No Benefit), as stated by the American Heart Association 1
For patients with complications or suboptimal results after PCI, it is reasonable to monitor for arrhythmia and ischemia for ≥24 hours or until the complication is resolved (Class IIa), according to the American Heart Association 1

Patient education before discharge about the possibility of post-stent chest symptoms and how to differentiate them from ischemic symptoms is recommended, as suggested by the American Heart Association 2
Continuation of prescribed antianginal medications used during the non-intensive phase (other than IV nitroglycerin) after discharge is recommended, according to the American Heart Association 2
Provision of sublingual nitroglycerin with clear instructions for use is recommended, as stated by the American Heart Association 2 and 3

For patients without indication for oral anticoagulation, dual antiplatelet therapy (DAPT) consisting of aspirin 75-100 mg and clopidogrel 75 mg daily for up to 6 months is recommended as the default strategy after PCI-stenting, according to the European Society of Cardiology 4 and 5
In patients at high bleeding risk but not at high ischemic risk, discontinue DAPT 1-3 months after PCI and continue with single antiplatelet therapy, as recommended by the European Society of Cardiology 6
For patients with atrial fibrillation or other indications for oral anticoagulation who undergo PCI, early cessation of aspirin (≤1 week) followed by continuation of oral anticoagulant and clopidogrel for up to 6 months in patients not at high ischemic risk, or up to 12 months in patients at high ischemic risk, is recommended, according to the European Society of Cardiology 5 and 7

Telephone follow-up can reinforce in-hospital instruction, provide reassurance, and answer patient questions, as suggested by the American Heart Association 2
Enrollment in a cardiac rehabilitation program can enhance patient education and compliance with the medical regimen, according to the American Heart Association 2
Multidisciplinary team approach involving physicians, nurses, dietitians, pharmacists, and rehabilitation specialists is recommended to support patients during recovery, as stated by the European Society of Cardiology 6 and the American Heart Association 2

Changes in the pattern or severity of anginal symptoms (more frequent, more severe, precipitated by less effort, or occurring at rest) should prompt immediate medical evaluation, as recommended by the American Heart Association 2 and 3